Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Age-related effects of COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI : results of the ISACS-STEMI COVID-19 registry
Authors:ID De Luca, Giuseppe (Author)
ID Algowhary, Magdy (Author)
ID Uguz, Berat (Author)
ID Oliveira, Dinaldo C. (Author)
ID Ganyukov, Vladimir (Author)
ID Busljetik, Oliver (Author)
ID Čerček, Miha (Author), et al.
Files:.pdf PDF - Presentation file, download (1,31 MB)
MD5: BB984F672035CD9B49B209667C6F7977
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Background: The constraints in the management of patients with ST-segment elevation myocardial infarction (STEMI) during the COVID-19 pandemic have been suggested to have severely impacted mortality levels. The aim of the current analysis is to evaluate the age-related effects of the COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI within the registry ISACS-STEMI COVID-19. Methods: This retrospective multicenter registry was performed in high-volume PPCI centers on four continents and included STEMI patients undergoing PPCI in March–June 2019 and 2020. Patients were divided according to age (< or ≥75 years). The main outcomes were the incidence and timing of PPCI, (ischemia time longer than 12 h and door-to-balloon longer than 30 min), and in-hospital or 30-day mortality. Results: We included 16,683 patients undergoing PPCI in 109 centers. In 2020, during the pandemic, there was a significant reduction in PPCI as compared to 2019 (IRR 0.843 (95%-CI: 0.825–0.861, p < 0.0001). We found a significant age-related reduction (7%, p = 0.015), with a larger effect on elderly than on younger patients. Furthermore, we observed significantly higher 30-day mortality during the pandemic period, especially among the elderly (13.6% vs. 17.9%, adjusted HR (95% CI) = 1.55 [1.24–1.93], p < 0.001) as compared to younger patients (4.8% vs. 5.7%; adjusted HR (95% CI) = 1.25 [1.05–1.49], p = 0.013), as a potential consequence of the significantly longer ischemia time observed during the pandemic. Conclusions: The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a 16% reduction in PPCI procedures, with a larger reduction and a longer delay to treatment among elderly patients, which may have contributed to increase in-hospital and 30-day mortality during the pandemic.
Keywords:ageing, ST-segment elevation myocardial infarction, COVID-19
Publication status:Published
Publication version:Version of Record
Year of publishing:2023
Number of pages:str. 1-14
Numbering:Vol. 12, issue 6, [article no.] 2116
PID:20.500.12556/DiRROS-28732 New window
UDC:616.1
ISSN on article:2077-0383
DOI:10.3390/jcm12062116 New window
COBISS.SI-ID:272793859 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 24. 3. 2026;
Publication date in DiRROS:31.03.2026
Views:84
Downloads:36
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Journal of clinical medicine
Shortened title:J. clin. med.
Publisher:MDPI
ISSN:2077-0383
COBISS.SI-ID:5405759 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back